Archives
AI Powers Drug Discovery
Generative AI is speeding drug discovery and clinical trial design, helping startups bring therapies to market faster and more efficiently.
Funding Falls Short for FemTech
Women’s health startups receive a small share of venture capital despite clear unmet clinical needs.
The Health Tech ROI Reckoning
Startups that fail to prove ROI face funding pressure, longer sales cycles, and consolidation, while companies showing real impact gain the advantage.
The End of "Virtual as Add-On"
Increased interest and emphasis around digital care delivery aims to improve outcomes and achieve consumer expectations for accessible, personalized healthcare.
Home-Based Care Becomes Scalable
Regulatory backing and tech-enabled solutions are enabling home-based care to scale rapidly, making it a mainstream model for hospitals and startups alike.
Next-Gen Chronic Care
Startups are using AI, digital therapeutics, and virtual care to improve outcomes and reduce costs for chronic conditions.
Cell & Gene Therapy Boom
With key FDA decisions pending in the first half of 2026 and an expected global market surge, CGT is poised to revolutionize medicine.
Consumers Take Health Optimization Direct
Direct-to-consumer diagnostic platforms and retail health optimization products are expanding rapidly as patients increasingly bypass traditional medical gatekeepers to self-manage their health data, wellness strategies, and preventive care outside clinical settings.